10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Supportive Care
13 articles
(Page 2)
Zinc Supplementation Reduces Severe Hand-Foot Skin Reaction in Cancer Patients
Study shows zinc supplements decrease severe hand-foot skin reactions from regorafenib cancer drug